Genomic epidemiology of the first two waves of SARS-CoV-2 in Canada.

McLaughlin, Angela; Montoya, Vincent; Miller, Rachel L; Mordecai, Gideon J; Worobey, Michael; Poon, Art F Y; Joy, Jeffrey B

McLaughlin, Angela; Montoya, Vincent; Miller, Rachel L; Mordecai, Gideon J; Worobey, Michael; Poon, Art F Y; Joy, Jeffrey B.

Afiliación

McLaughlin A; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Montoya V; Bioinformatics, University of British Columbia, Vancouver, Canada.
Miller RL; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Mordecai GJ; British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada.
Worobey M; Department of Medicine, University of British Columbia, Vancouver, Canada.
Joy JB; Department of Ecology and Evolution, University of Arizona, Tucson, United States.

Elife ; 112022 08 02.

Article en En | MEDLINE | ID: mdl-35916373

Asunto(s)

COVID-19; SARS-CoV-2; COVID-19/epidemiología; Genómica/métodos; Humanos; Ontario; Filogenia; SARS-CoV-2/genética

Palabras clave

COVID-19; SARS-CoV-2; epidemiology; evolutionary biology; genomics; global health; molecular epidemiology; phylogenetics; public health; viruses

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Risk_factors_studies / Screening_studies País/Región como asunto: America do norte Idioma: En Revista: Elife Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google